Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Islet cell antibodies, but not glutamic acid decarboxylase antibodies, are decreased by plasmapheresis in patients with newly diagnosed insulin-dependent diabetes mellitus.

Sundkvist G, Hagopian WA, Landin-Olsson M, Lernmark A, Ohlsson L, Ericsson C, Ahlmén J.

J Clin Endocrinol Metab. 1994 May;78(5):1159-65.

PMID:
8175973
2.
3.

IA-2-autoantibodies complement GAD65-autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblings. The Belgian Diabetes Registry.

Gorus FK, Goubert P, Semakula C, Vandewalle CL, De Schepper J, Scheen A, Christie MR, Pipeleers DG.

Diabetologia. 1997 Jan;40(1):95-9.

PMID:
9028724
4.

Antibodies to glutamic acid decarboxylase and insulin-dependent diabetes in patients with autoimmune polyendocrine syndrome type I.

Tuomi T, Björses P, Falorni A, Partanen J, Perheentupa J, Lernmark A, Miettinen A.

J Clin Endocrinol Metab. 1996 Apr;81(4):1488-94.

PMID:
8636356
5.

Glutamic acid decarboxylase and ICA512/IA-2 autoantibodies as disease markers and relationship to residual beta-cell function and glycemic control in young type 1 diabetic patients.

Zanone MM, Catalfamo E, Pietropaolo SL, Rabbone I, Sacchetti C, Cerutti F, Trucco M, Cavallo-Perin P.

Metabolism. 2003 Jan;52(1):25-9.

PMID:
12524658
6.

Use of an islet cell antibody assay to identify type 1 diabetic patients with rapid decrease in C-peptide levels after clinical onset. Belgian Diabetes Registry.

Decochez K, Keymeulen B, Somers G, Dorchy H, De Leeuw IH, Mathieu C, Rottiers R, Winnock F, ver Elst K, Weets I, Kaufman L, Pipeleers DG, Gorus FK; Belgian Diabetes Registry.

Diabetes Care. 2000 Aug;23(8):1072-8.

7.

Autoantibodies against glutamic acid decarboxylase 65 in Japanese patients with insulin-dependent diabetes mellitus (IDDM).

Yano M, Moriuchi R, Kawasaki E, Watanabe M, Saito K, Takino H, Akazawa S, Miyamoto T, Nagataki S.

J Autoimmun. 1995 Feb;8(1):83-96.

PMID:
7734039
8.

High levels of antigen-specific islet antibodies predict future beta-cell failure in patients with onset of diabetes in adult age.

Borg H, Gottsäter A, Landin-Olsson M, Fernlund P, Sundkvist G.

J Clin Endocrinol Metab. 2001 Jul;86(7):3032-8.

PMID:
11443164
9.

UKPDS 25: autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes. UK Prospective Diabetes Study Group.

Turner R, Stratton I, Horton V, Manley S, Zimmet P, Mackay IR, Shattock M, Bottazzo GF, Holman R.

Lancet. 1997 Nov 1;350(9087):1288-93. Erratum in: Lancet 1998 Jan 31;351(9099):376.

PMID:
9357409
10.

Islet cell antibodies in insulin-dependent (type 1) diabetic children treated with plasmapheresis.

Marner B, Lernmark A, Ludvigsson J, MacKay P, Matsuba I, Nerup J, Rabinovitch A.

Diabetes Res. 1985 Sep;2(5):231-6.

PMID:
3905187
11.
12.

Autoantibodies to glutamic acid decarboxylase (GAD) detected by an immuno-trapping enzyme activity assay: relation to insulin-dependent diabetes mellitus and islet cell antibodies.

Martino GV, Tappaz ML, Braghi S, Dozio N, Canal N, Pozza G, Bottazzo GF, Grimaldi LM, Bosi E.

J Autoimmun. 1991 Dec;4(6):915-23.

PMID:
1812896
13.

Diabetes-associated autoantibodies in relation to clinical characteristics and natural course in children with newly diagnosed type 1 diabetes. The Childhood Diabetes In Finland Study Group.

Sabbah E, Savola K, Kulmala P, Veijola R, Vähäsalo P, Karjalainen J, Akerblom HK, Knip M.

J Clin Endocrinol Metab. 1999 May;84(5):1534-9.

PMID:
10323375
14.

Combined screening for autoantibodies to IA-2 and antibodies to glutamic acid decarboxylase in first degree relatives of patients with IDDM. The DENIS Study Group. Deutsche Nikotinamid Interventions-Studie.

Seissler J, Morgenthaler NG, Achenbach P, Lampeter EF, Glawe D, Payton M, Christie M, Scherbaum WA.

Diabetologia. 1996 Nov;39(11):1351-6.

PMID:
8933004
15.

Prevalence of autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus.

Seissler J, Amann J, Mauch L, Haubruck H, Wolfahrt S, Bieg S, Richter W, Holl R, Heinze E, Northemann W, et al.

J Clin Invest. 1993 Sep;92(3):1394-9.

17.

Types of pediatric diabetes mellitus defined by anti-islet autoimmunity and random C-peptide at diagnosis.

Redondo MJ, Rodriguez LM, Escalante M, Smith EO, Balasubramanyam A, Haymond MW.

Pediatr Diabetes. 2013 Aug;14(5):333-40. doi: 10.1111/pedi.12022. Epub 2013 Mar 5.

PMID:
23458188
19.

Autoantibodies associated with presymptomatic insulin-dependent diabetes mellitus in women.

Whittingham S, Byron SL, Tuomilehto J, Zimmet PZ, Myers MA, Vidgren G, Rowley MJ, Feeney SJ, Koskela P, Tuomilehto-Wolf E, Mackay IR.

Diabet Med. 1997 Aug;14(8):678-85.

PMID:
9272595

Supplemental Content

Support Center